NCT03451890View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 9, 2018

Primary Completion Date

September 26, 2018

Study Completion Date

September 26, 2018

Conditions
Healthy Participants
Interventions
DRUG

E2730

oral capsule

DRUG

Placebo

oral capsule

Trial Locations (1)

90806

Collaborative Neuroscience Network, Long Beach

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT03451890 - A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730 in Healthy Participants | Biotech Hunter | Biotech Hunter